17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response.

about

17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response.

Item

http://www.wikidata.org/entity/Q43187814

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

17-Week Delay Surgery after Ch ...... omplete Pathological Response.

@en

17-Week Delay Surgery after Ch ...... omplete Pathological Response.

@nl

type

Item

label

17-Week Delay Surgery after Ch ...... omplete Pathological Response.

@en

17-Week Delay Surgery after Ch ...... omplete Pathological Response.

@nl

prefLabel

17-Week Delay Surgery after Ch ...... omplete Pathological Response.

@en

17-Week Delay Surgery after Ch ...... omplete Pathological Response.

@nl

P1476

17-Week Delay Surgery after Ch ...... Complete Pathological Response

@en

P2093

Anabela Rocha

http://www.w3.org/2001/XMLSchema#string

Carlos Lopes

http://www.w3.org/2001/XMLSchema#string

Filipa Moreno

http://www.w3.org/2001/XMLSchema#string

Manuel T Gomes

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer.

Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.

Tumor regression grades: can they influence rectal cancer therapy decision tree?

Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?

MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience.

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial.

Where next with preoperative radiation therapy for rectal cancer?

Prognostic significance of partial tumor regression after preoperative chemoradiotherapy for rectal cancer: a meta-analysis.

Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection.

MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.

P304

816491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/816491

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Marisa D Santos

P577

2015-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283959616

http://www.w3.org/2001/XMLSchema#string

P698

26579325

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4633564

http://www.w3.org/2001/XMLSchema#string